📣New opportunity with REMEDi4ALL! The REMEDi4ALL Partnering Portal is now open – creating a pathway for repurposing projects to collaborate with REMEDi4ALL. If you’re considering a proposal, we encourage you to first connect with the REMEDi4ALL Concierge. More➡️ https://loom.ly/xs12IxA

On 11–12 September, the REMEDi4ALL consortium gathered in Ljubljana for our fourth General Assembly Meeting. Over 50 members came together to reflect on progress, share achievements, and set priorities for the final two years of the project. Read more here➡️ https://loom.ly/jREI4bU

🎓New Digital Academy event! Join REMEDi4ALL’s Digital Academy with King’s College & LifeArc for a webinar on IP Strategies for Repurposing. Learn how to protect discoveries, tackle regulatory issues & move findings closer to patients. 🗓️ 21 Nov, 14:00–15:30 CET 🔗 https://loom.ly/dsFZvjU

🙌 Thank you to all who joined the #REMEDi4ALL General Assembly in Ljubljana. Our community’s dedication & expertise drive progress in #DrugRepurposing – working together to bring safe & effective drugs to more patients. ➡️ Updates: https://remedi4all.org/#REMEDi4ALL#DrugRepurposing #DrugRepurposing

🇸🇮 We’re live from Ljubljana for the #REMEDi4ALL General Assembly! After 3️⃣ years of collaboration, we’re looking back on our achievements & shaping the next steps to accelerate #PatientCentred medicines repurposing in Europe, & beyond. ➡️ More here: https://remedi4all.org #DrugRepurposing

📢Got a proposal for a #RareDisease #ClinicalTrial? Join our associated partner @lifearc.bsky.social Webinar & learn how experts can support you from protocol design & regulatory navigation to #PatientEngagement & #DataManagement. 🗓8 Oct 2025 ➡️Register: [email protected]

📣 REMEDi4ALL consortium partner Medicines for Europe, is looking for a Value Added Medicines Policy Manager with a passion for drug repurposing and interest in shaping policy to join their team in Brussels and lead their work within the REMEDi4ALL project! Apply here➡️ https://loom.ly/9ARRjuI

REMEDi4ALL and #iDR25 have been featured in Forbes, highlighting case studies in malaria, MND, CVS and RRP, the role of adaptive trial designs and patient input, and the need for stronger US–EU collaboration in drug repurposing. 📖 https://loom.ly/iY05I1A

Curious about drug repurposing and its impact? 🎥 Our latest video explains how repurposing existing medicines can accelerate access to effective treatments, benefitting patients and healthcare systems worldwide. Learn more 🌐➡️ www.remedi4all.org

📣 Funders of repurposing: planning a call for #DrugRepurposing research? Our Practical Guide gives you everything you need to get started, including real-world examples from the #REMEDi4ALL Funders Network. ➡️ Download: https://loom.ly/njyk7j0#DrugRepurposing#REMEDi4ALL#ResearchFunding

🔬 Looking to accelerate drug repurposing? Explore the REMEDi4ALL in-silico Drug Repurposing catalogue: an open resource helping researchers find new uses for existing drugs with advanced computational tools. Learn more: 📹 Guide: https://loom.ly/e0bBYjc 📄 Publication: https://loom.ly/F7KIRjM

Thanks to everyone who joined today’s webinar on AI-driven #DrugRepurposing clinical trials! Together with Beacon for Rare Diseases & Cures Within Reach, we explored how funding can turn predictions into patient benefit—especially in #RareDiseases. ➡️ More: https://loom.ly/5zgrVP4

🚨 New from REMEDi4ALL: a framework to assess the value of repurposed medicines! ✅ Tailored to unique needs of drug repurposing ✅ Supports early funding justification ✅ Validated across multiple stakeholders ✅ Free and open-access Explore here ⬇️ https://loom.ly/x6Y46o8

Join Beacon for Rare Diseases with Cures Within Reach & REMEDi4ALL on 31 July for a webinar exploring a new funding opportunity for AI-powered drug repurposing trials in rare diseases. 📅 31 July 🕞15:30 BST | 16:30 CEST 📝 Register: https://loom.ly/5zgrVP4 💡More info: https://loom.ly/QBMqtZY

💡At a recent REMEDi4ALL workshop, funders, observers and REMEDi4ALL consortium members explored our new framework for judging the project value of repurposed medicines. 📄Discover the resource here: https://loom.ly/x6Y46o8 👥Read about the workshop here: https://loom.ly/8LNkUGE

🧠 REMEDi4ALL joined Bionow’s 2025 Neuroscience Conference to discuss UK drug repurposing in neurological disorders! We spoke on the “State of the Nation” panel and reconnected with key players including UCL, Alzheimer’s UK & Serenatis Bio. More here ➡️ https://loom.ly/0N6y7IM

Want to revisit some of the #iDR25 Conference sessions? All resources are now available online for attendees, including: ✅delegate list ✅session recordings ✅ session slides ✅ posters presented ✅ articles, video highlights, photo gallery and more! 👉 https://loom.ly/_xSviOI

📢 REMEDi4ALL SOPs now on Zenodo! Explore our first 12 SOPs supporting best practices in drug repurposing, from in silico workflows to FAIR data & phospholipidosis assays. 🔗 https://loom.ly/TuB6ihg #DrugRepurposing #OpenScience #REMEDi4ALL

🔍 What’s new in the REMEDi4ALL Digital Academy? We’ve just added: 📄 New case studies to deepen your understanding of drug repurposing in action Want to explore our accessible digital learning platform? Swipe through to learn more ➡️ #REMEDi4ALL #DigitalAcademy #DrugRepurposing

👥 At the OIFE Annual Meeting 2025, REMEDi4ALL's Dalma Hosszú and Réka Pozsár (SRI) held a patient workshop to explore real-life challenges of living with OI. 🧠 Insights from 31 participants are now helping shape repurposing priorities. Thanks to OIFE for the warm welcome and collaboration!

💡 Funding now open for AI-driven drug repurposing projects! Cures Within Reach is seeking proposals for clinical trials to validate AI-driven drug repurposing. Open to global applicants in any disease area! 📅 Apply by 25 Aug 2025 👉 More info: https://loom.ly/QBMqtZY

📢 Applications for the REMEDi4ALL Hackathon are now closed! Thank you to everyone who applied! We are now reviewing your applications and look forward to bringing together an inspiring group in Barcelona this October. More REMEDi4ALL training➡️ loom.ly/thCPXrc

What is drug repurposing—and why does it matter? 💡 Discover how repurposing existing medicines can speed up access to treatments & benefit healthcare systems. Watch REMEDi4ALL’s explainer video & learn more: 🔗 www.youtube.com/watch?v=w69O... #DrugRepurposing #REMEDi4ALL

💻 Missed the REMEDi4ALL academic bootcamp? Catch up with new content now available in our Digital Academy! 📚 The Regulation module has fresh insights on regulatory frameworks + engaging with regulators. 🔗 loom.ly/3UeBnjA #RegulatoryScience #DigitalAcademy

🚨Why join the REMEDi4ALL Hackathon? Applications are now open for our hackathon on drug repurposing – here’s why you should join👇 💡Mentorship from top experts 🤝Real-world challenges 🌍European networking ⚡Lasting impact 📍Barcelona - 6–10 Oct 🔗 loom.ly/2V3NnfI

📣#iDR25 making headlines! El País spotlights drug repurposing advances — including how a hypertension pill may help children with epidermolysis bullosa. Great to see REMEDi4ALL and #iDR25 featured as key #DrugRepurposing initiatives! 🔗Read more: loom.ly/qzQoFDY

#iDR25 – That’s a wrap! 🌍 300+ joined us in Amsterdam for two days of panels, posters, and powerful discussions on smarter routes to repurposed medicines. 👥 Thanks to our speakers and attendees for your insights, energy & contributions. 📖Highlights: remedi4all.org/idr25-wraps-...

Day 2 of #iDR25 is in full swing! We're tackling #DrugRepurposing, AI, #ClinicalTrial innovation, #PatientSccess, & more. 📸 Daria Julkowska, @erdera.bsky.social: “ #ERDERA aims to deliver real health gains for #RareDisease patients in the next decade.” #DrugRepurposing

🎉 We are on Day 2 of #iDR25! We have an amazing array of speakers from LifeArc, the European Medicines Agency, UCL, Tiefenbacher Group, Chan Zuckerberg Initiative, Medicines for Europe, to name only a few. ➡️ Check all the tracks here: remedi4all.org/2025-interna... #DrugRepurposing #PatientCentric

This afternoon at #iDR25: three parallel tracks! 🤖 Advances in AI for Drug Repurposing 💊 Repurposing for the Under-Served 🔗 Pathways to Patient Access Global experts, big topics. Check the agenda: remedi4all.org/2025-interna... 🤔 Which one would you follow?

This afternoon at #iDR25: three parallel tracks! 🤖 Advances in AI for Drug Repurposing 💊 Repurposing for the Under-Served 🔗 Pathways to Patient Access Global experts, big topics. Check the agenda: remedi4all.org/2025-interna... 🤔 Which one would you follow?

🔴 We're live from #iDR25 discussing AI-enhanced clinical decisions, European platform trials tackling major depression #MMD, initiatives in repurposing for children and substance use, and more. New and exciting insights to initiatives in the #DrugRepurposing landscape!

🌟 #iDR25 has officially begun! This morning we explore EU funding, patient voices & national strategies. Proud to hear from @eatris.bsky.social, Beacon for Rare Diseases, ZonMw, Dutch Ministry of Health & more! Let’s go! 📸 Anton Ussi (EATRIS-ERIC) opening the conference.

The #iDR25 workshops are in full flow in Amsterdam! The Health Technology Assessment session has just concluded, and the Regulatory workshop is about to begin, featuring the #REPURPOLIS board game. ➡️ Check out the packed agenda for the next 2 days: remedi4all.org/2025-interna...

Sponsor Announcement! We're delighted to welcome LifeArc as an #iDR25 Gold Sponsor! LifeArc transforms science into impact – aiming for a world where no one with a rare disease is left behind. More on LifeArc: www.lifearc.org 🎟️ #iDR25 tickets: remedi4all.org/2025-interna...

We're excited to welcome you to Amsterdam next week for #iDR25 - the 2025 International Drug Repurposing Conference! Expect a dynamic programme with expert speakers all focused on advancing repurposing for patient benefit. 🎟️ Last tickets: loom.ly/mYozy3E

🚨 Breaking news: Dompé is an #iDR25 Platinum Sponsor! With 130+ years of history, Dompé blends a family-run business with the innovation of a start-up. Active across the pharma value chain, they're a great fit for our AI track. 🔗 Learn more: loom.ly/xGqLsX4

🚨Last chance!🚨 Only a few spots left for the pre-#iDR25 workshops on 6 May in Amsterdam! Join experts and explore: 1️⃣ Health Technology Assessment (HTA) 2️⃣ Regulatory pathways for medicinal product repurposing ⏳ Don’t miss out - register now!👉 loom.ly/0sIBcrg

🚨 Apply now for the 2025 REMEDi4ALL Hackathon! Learn, collaborate & tackle real-world drug repurposing challenges in a unique 5-day training experience with peers & leading experts. 📅 6–10 Oct 2025 📍 Montserrat, Barcelona, Spain 🔗 Details: remedi4all.org/resources/re...

Interested in attending the #iDR25 workshop series? Here's HTA workshop organiser Dalma Hosszú on how the workshop will shape your understanding of the HTA landscape in drug repurposing. ➡️ Limited places are still available - sign-up here: loom.ly/0sIBcrg

LifeArc joins REMEDi4ALL, bringing extensive expertise in translational research and drug development! By joining forces, REMEDi4ALL and LifeArc aim to accelerate the development and delivery of innovative repositioned and repurposed medicines. More➡️ loom.ly/FJBlWXE

Join us in Amsterdam on 7–8 May for #iDR25 – the International Drug Repurposing Conference! 👉 Book now to join patients, scientists, clinicians, regulators, policy-makers, funders and business leaders working to make #DrugRepurposing the new normal: loom.ly/xGqLsX4

How do patients gain access to repurposed drugs? 💡 Join us in Amsterdam on 6 May 2025 for a deep dive into Health Technology Assessment (#HTA) - a crucial tool for ensuring access to repurposed medicines. 📌 Spots are limited - register today! loom.ly/0sIBcrg

The #iDR25 conference will feature a special session dedicated to lightning talks. Don't miss the chance to hear from speakers with diverse backgrounds, including patent law, patient advocacy, academic research & industry. 📅 7-8 May in Amsterdam Register now: loom.ly/uCE9JsU #R4ALL

Meet the speakers for the #iDR25 Regulatory Workshop (6 May, Amsterdam​) 🗣️ Violeta Stoyanova-Beninska – Senior Scientific Specialist, EMA 🗣️ Rosan Vegter – Senior Rare Disease Innovation Officer, EATRIS 🗣️ Nadina Grosios – Founder, oncoKnow Register now!➡️ loom.ly/rfElcGg

Meet the speakers for Workshop1️⃣ at #iDR25! 💡HTA: a key tool for patient access | 6 May 🗣️ Dalma Hosszú – Head of Patient-centricity, Syreon Research Institute 🗣️ András Pérenyi – Innovation & Investment expert, Syreon Research Institute Register now!➡️ loom.ly/0sIBcrg

#iDR25 speaker Álvaro Acosta Serrano and his team published ground-breaking research on #repurposing #nitisinone—a rare disease treatment—to fight #malaria! Hear the full story from Álvaro at #iDR25! 🗞️ Read: loom.ly/4zpqoJQ 👉 #iDR25: loom.ly/xGqLsX4

Learn more about HTA & regulation in Drug Repurposing! Join the #iDR25 workshop series on 6 May in Amsterdam. Workshop 1️⃣: HTA—a key tool for patient access 🔧 Workshop 2️⃣: Navigating the regulatory path for repurposing 🗺️ Register here! ➡️ loom.ly/0sIBcrg

#iDR25 is fast approaching! Hear from Headline Sponsor ZonMw on why this event is essential for anyone interested in drug repurposing. ✅Specialised tracks ✅Expert speakers ✅Insightful posters and lightning talks ✅Networking opportunities Register now➡️ loom.ly/xGqLsX4

📣 New REMEDi4ALL Publication! Researchers at the University of Ljubljana review the overactive inflammatory response in COVID-19, supporting one of REMEDi4ALL’s Demonstrator Projects. 🔎 Learn more: loom.ly/gRsMYoc 🗞️ Full article: loom.ly/gRsMYoc